Free tool

Diagnostics stocks

We cover 13 companies grouped under the Diagnostics theme. The median market value in the group is $291.73M. Across the group, the median move over the past trading day is +1.11%. Price change over the past year runs from −45.8% to +164.8% across the middle 80 percent of the group, with a median of +7.2%.

Other lists in this group

Table

13 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
PSNLPersonalis, Inc.$1.84BSmall cap+267.02%
OPKOPKO Health, Inc.$1.11BSmall cap+7.19%
QDELQuidelOrtho Corporation$1.03BSmall cap−45.57%
FLGTFulgent Genetics, Inc.$548.93MSmall cap−7.34%
NNNNAnbio Biotechnology$343.67MSmall cap−84.06%
BDSXBiodesix, Inc.$296.22MSmall cap+186.48%
MYGNMyriad Genetics, Inc.$291.73MSmall cap−45.84%
OSUROraSure Technologies, Inc.$260.70MSmall cap+20.38%
LUCDLucid Diagnostics Inc.$190.95MSmall cap−12.93%
IMDXInsight Molecular Diagnostics Inc.$145.30MSmall cap+78.31%
PCSCPerceptive Capital Solutions Corp$123.25MSmall cap+13.16%
QUCYQuantum Cyber N.V.$110.13MSmall cap−20.93%
BNRBurning Rock Biotech Limited$108.84MSmall cap+13.95%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse